Timothy Mitchell

Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK

Gammadelta Therapeutics Ltd. is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company was founded by Raj Mehta in 2016 and is headquartered in London, the United Kingdom.

Discuva Ltd. develops antibiotics and drug-resistant pathogens. It is a drug discovery company focused on the creation of microbial against new emerging and drug-resistant bacterial pathogens. The company is headquartered in Cambridge, the United Kingdom.

Nanna Therapeutics Ltd. engages in development of pharmaceutical products. It provides drugs for combat debilitating neurodegenerative, inflammatory, cardiovascular and metabolic diseases as well as many cancers. The company is headquartered in Cambridge, the United Kingdom.

Oval Medical Technologies Ltd. manufactures drug delivery devices focusing on vials, prefilled syringes, and autoinjectors. It provides an environment for the storage of all drugs including fragile biologics. The company was founded by Matthew Young in 2009 and is headquartered in Cambridge, the United Kingdom.

Food & Drug Analytical Services Ltd. provides pharmaceutical quality control testing services. Its services include raw material, product release, and stability testing, microbiology, and development services. The firm also offers analytical methodologies, ICH stability storage, development and validation services. The company was founded in 2004 and is headquartered in Nottingham, the United Kingdom.

Locate Bio Ltd. operates as a regenerative medicine development company. The firm focuses on clinical problems in which regeneration of human tissue will displace biomaterial or drug therapies. Its products are orthopaedic matrices with unique properties for hard to heal clinical applications. The company was founded by Robin Quirk and is headquartered in Nottingham, the United Kingdom.

Part of Boston Scientific Corp., Provensis Ltd. is a British company that provides health care services. The company is based in Camberley, UK. The company was founded in 1999 by Paul Bernard Harper.

Monica Healthcare Ltd. develops wearable devices that use wireless technologies to facilitate globally accessible obstetric services in the home and hospital. It offers Monica AN24 is a small leadless device that accurately monitors FHR, MHR, and UC using abdominal ECG electrodes. The device also offers a wireless ambulatory monitoring solution for maternal-fetal monitoring during about and delivery and for the homecare setting. The company was founded by Carl William Barratt, Barrie Robert Hayes-Gill, Jean-François Piéri and Terence Ronald Paul Martin in May 2005 and is headquartered in Nottingham, the United Kingdom.

i2 Ltd. provides investigative analysis and visualization software for law enforcement and commercial organizations. The company was founded in 1990 by Michael Hunter and Timothy Spiers and is headquartered in Cambridge, UK.

Mobile Systems International provides market research services to businesses. The private company is based in London, UK, and has subsidiaries in the United States. The British company offers interviews with business decision makers, gamers, consumers, and industry employees to help companies raise money, report to shareholders, and plan marketing and competitor strategies. The company uses the ISO classification framework to value brands and ensure that companies are not valued solely on their balance sheet.

Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom.

Molten Ventures (Private Equity) (Molten Ventures) is a venture capital firm subsidiary of Molten Ventures Plc founded in 1998 by Simon Christopher Cook and Stuart Malcolm Chapman. The firm is headquartered in London, United Kingdom.

Part of Abbott Laboratories, Unipath Ltd. is a British company that manufactures female healthcare products. The company is based in Bedford, UK. The company was founded in 1946 by Paul James Davis. Unipath was acquired by Alere, Inc. from Unilever NV on 2001-12-20 for $146.54 million.

The Engineering & Physical Sciences Research Council provides funds for research and training in engineering and the physical sciences. It covers range of subjects from mathematics to material science and from information technology to structural engineering. The firm offers services to the users and beneficiaries of chemical, communications, construction, electrical, electronic, energy, engineering, information technology, pharmaceutical, process and other industries. The company was founded in 1994 and is headquartered in Swindon, the United Kingdom.

Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The company is based in Maidenhead, UK. Founded in 1987.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK.

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation.

Avacta Life Sciences Ltd. provides powerful reagents for research and diagnostics. The company is headquartered in Wetherby, the United Kingdom.

Iksuda Therapeutics Ltd. operates as a biotechnology company which specializes in the development of next generation biotherapeutics. It creates new generation biological therapeutics through advanced glycosylation and conjugation technologies. The company has core expertise in protein/peptide fictionalization and glycosylation technologies, imparting improved pharmacokinetic properties to a broader range of biological therapeutics. It was founded by David John Simpson and Andrew Watts on November 21, 2007 and is headquartered in Newcastle upon Tyne, the United Kingdom.

ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom.

Glaxosmithkline Services Unlimited Ltd. develops, manufactures and markets pharmaceutical products. The company was incorporated on March 23, 1972 and is headquartered in Brentford, the United Kingdom.

BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands.